“alzheimers-disease” Archives

in
Entry Author Date Location
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials 02/06/19 San Francisco
FDA Rejects Alkermes Depression Drug, Asks for More Clinical Data 02/01/19 Boston
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test 01/30/19 National
Dewpoint Debuts with $60M to Target Protein Droplets Linked to Disease 01/30/19 Boston
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
Tetra Inks Deal with Shionogi to Support Fragile X, Alzheimer’s R&D 01/09/19 Detroit Ann Arbor
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs 01/07/19 San Francisco
San Francisco Biotech: The Next Generation—Photos and Takeaways 12/26/18 San Francisco
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Eli Lilly Partners with AC Immune on Tau Blockers for Alzheimer’s 12/12/18 Indiana
Viracta, Neurelis & More: The Latest in San Diego Biotech 12/05/18 San Diego
Salk Team Awarded 8-Year, $19.2M Grant for Alzheimer’s Research 11/09/18 San Diego
Allogene, Cortexyme & RDMD Headline Xconomy’s Dec. 5 Biotech Forum 11/08/18 San Francisco
Rainwater Foundation Deploys Millions Toward Rare Brain Disease, PSP 11/07/18 Texas
Win $2 Million to Solve Alzheimer’s: New Prize Will Reward Fresh Ideas 11/05/18 Texas
Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs 11/01/18 San Francisco
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
Still Seeking Pharma Partner, Phoenix Bio Adds $1M in Angel Funding 10/25/18 Texas
Swabbing DNA on Phones Reveals Mysteries of Microbial World Around Us 10/10/18 Wisconsin
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups   07/27/18 National
Eisai & Biogen Reveal Promising Alzheimer’s Data, But Questions Linger 07/26/18 Boston
Alector Snags $133M to Activate Immune Cells Against Neurodegeneration 07/25/18 San Francisco
Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike 07/19/18 Boston
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Biogen, Eisai Claim Success in New Analysis of Failed Alzheimer’s Study 07/06/18 Boston
Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post 07/02/18 Boston
What’s Hot in Seattle Biotech: Tech, Life Sciences Convergence & More 06/19/18 Seattle
Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates 06/15/18 National
Page 1 of 5 next page »